In trials like SURMOUNT, Tirzepatide (15 mg weekly) achieved impressive results, showing approximately 20-21% mean weight loss over about 72 weeks
- KLOW, GHK-Cu
However, GLP-1 drugs have surged in popularity due to their ability to support major weight loss and reduce risks for chronic conditions, including heart disease
Pancreas 45 , 584592, doi:10.1097/MPA.0000000000000505 (2016)
Choose Injection If They are also ideal for patients requiring a dependable, potent arousal response unaffected by external conditions such as nasal health or timing inconsistencies, and require more help than PDE5 inhibitors can provide
Why Muscle Aches May Occur During GLP-1 Therapy GLP-1 medications work by slowing gastric emptying and signaling fullness in the brain, which reduces appetite and food intake dramatically in the first weeks